Watch AMGN. Know when insiders buy.
One email the day a filing lands. Free.
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $10.1B | +9.5% | 72.0% | $3.5B | $2.4B | +65.9% | 4.37 | $4B | $513M | $3.5B | Aug 5 |
| Q1 2026 · Mar 31 | $8.6B | +5.8% | 68.2% | $2.7B | $1.8B | +5.1% | 3.34 | $2.2B | $712M | $1.5B | Aug 5 |
| Q4 2025 · Dec 31 | $9.9B | +8.6% | 69.8% | $2.7B | $1.3B | +112.6% | 2.46 | $1.6B | $642M | $961M | Aug 5 |
| Q3 2025 · Sep 30 | $9.6B | +12.4% | 67.8% | $2.5B | $3.2B | +13.6% | 5.93 | $4.7B | $436M | $4.2B | Feb 13 |
| Q2 2025 · Jun 30 | $9.2B | +9.4% | 67.2% | $2.7B | $1.4B | +92.0% | 2.65 | $2.3B | $369M | $1.9B | Aug 5 |
| Q1 2025 · Mar 31 | $8.1B | +9.4% | 63.6% | $1.2B | $1.7B | — | 3.20 | $1.4B | $411M | $980M | May 1 |
| Q4 2024 · Dec 31 | $9.1B | +10.9% | 65.7% | $2.3B | $627M | −18.3% | 1.16 | $4.8B | $371M | $4.4B | Feb 13 |
| Q3 2024 · Sep 30 | $8.5B | +23.2% | 61.1% | $2B | $2.8B | +63.6% | 5.22 | $3.6B | $257M | $3.3B | Feb 13 |
| Q2 2024 · Jun 30 | $8.4B | — | 61.4% | $1.9B | $746M | — | 1.38 | $2.5B | $238M | $2.2B | Feb 13 |
| Q1 2024 · Mar 31 | $7.4B | — | 57.0% | $991M | −$113M | — | -0.21 | $689M | $230M | $459M | Feb 13 |
| Q4 2023 · Dec 31 | $8.2B | — | 62.0% | $1.3B | $767M | — | 1.43 | $538M | $249M | $289M | Feb 13 |
| Q3 2023 · Sep 30 | $6.9B | — | 73.8% | $2B | $1.7B | — | 3.22 | $2.8B | $248M | $2.5B | Feb 13 |
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $36.8B | 67.2% | $9.1B | $7.7B | 21.0% | 14.23 | $10B | $1.9B | $8.1B | $0 | $5.1B |
| FY2024 · to Dec 31 | $33.4B | 61.5% | $7.3B | $4.1B | 12.2% | 7.56 | $11.5B | $1.1B | $10.4B | $200M | $4.8B |
| FY2023 · to Dec 31 | $28.2B | 70.0% | $7.9B | $6.7B | 23.8% | 12.49 | $8.5B | $1.1B | $7.4B | $0 | $4.6B |
| FY2022 · to Dec 31 | $26.3B | 75.7% | $9.6B | $6.6B | 24.9% | 12.11 | $9.7B | $936M | $8.8B | $6.4B | $4.2B |
| FY2021 · to Dec 31 | $26B | 75.2% | $7.6B | $5.9B | 22.7% | 10.28 | $9.3B | $880M | $8.4B | $5B | $4B |
| FY2020 · to Dec 31 | $25.4B | 75.8% | $9.1B | $7.3B | 28.6% | 12.31 | $10.5B | $608M | $9.9B | $3.5B | $3.8B |
Every number comes from AMGEN INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.